CA
NZ
UK
AU
IND
US
A Form 4 filed on September 4, 2026, reports that Cory Vieira, Chief Accounting Officer of Pagaya Technologies Ltd. (NASDAQ:PGY), acquired 5,208 Class A Ordinary Shares through restricted stock unit vesting and sold 3,075 shares to satisfy tax withholding obligations on September 2, 2026.
Control Empresarial de Capitales S.A. de C.V., a 10% owner and director-affiliated entity of PBF Energy Inc. (NYSE:PBF), filed a Form 4 on September 4, 2026, reporting the sale of 100,000 Class A Common Shares on September 2, 2026.
A Form 4 filed on September 4, 2026, disclosed that Luca Zaramella, EVP and Chief Operating Officer of Mondelez International, Inc. (NASDAQ:MDLZ), exercised stock options and surrendered shares on September 2, 2026.
Almir Ambeskovic, CEO of TheFork at TripAdvisor, Inc., filed a Form 4 on September 4, 2026, disclosing the sale of 8,000 shares of TripAdvisor common stock on September 2, 2026.
Jonathan Vassil, Chief Revenue Officer of Toast, Inc. (NYSE:TOST), filed a Form 4 on September 4, 2026, reporting stock option exercises and share sales that occurred on September 2, 2026, pursuant to a Rule 10b5-1 trading plan.
Lantheus Alpha Therapy, LLC filed a Form 4 with the SEC on September 4, 2026, disclosing the sale of common stock in Perspective Therapeutics, Inc. (NASDAQ:CATX) on September 2, 2026.
Tali Notman, Chief Revenue Officer of JFrog Ltd, filed a Form 4 on September 4, 2026, disclosing the sale of 19,157 ordinary shares on September 2, 2026, to cover statutory tax withholding obligations tied to the vesting of Restricted Stock Units.
Eduard Grabscheid, Chief Financial Officer of JFrog Ltd. (NASDAQ:FROG), filed a Form 4 on September 4, 2026, disclosing sales of ordinary shares on September 2 and September 3, 2026, along with a tax-withholding disposition connected to a restricted stock unit vesting event.
Avi Shauli, Chief Technology Officer of Riskified Ltd. (NYSE:RSKD), filed a Form 4 on September 4, 2026, reporting the sale of 30,000 Class A Ordinary Shares on September 2, 2026.
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corporation, filed a Form 4 on September 4, 2026, reporting option exercises and open-market share sales that took place on September 3, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Please wait processing your request...